Skip to content

Evaluation of Efficacy and Safety of Single and Multiple Therapy of Herbal Medicine/Chuna Therapy on Non-specific Chronic Low Back Pain: A Study Protocol for Multicenter, 3-arm, Randomized, Single Blinded, Parallel Group, Incomplete Factorial Design, Pilot Study -

Evaluation of Efficacy and Safety of Single and Multiple Therapy of Herbal Medicine/Chuna Therapy on Non-specific Chronic Low Back Pain: A Study Protocol for Multicenter, 3-arm, Randomized, Single Blinded, Parallel Group, Incomplete Factorial Design, Pilot Study -

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03132974
Enrollment
150
Registered
2017-04-28
Start date
2018-09-01
Completion date
2021-12-31
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Brief summary

The Purpose of this trial is to investigate the efficacy and safety of herbal medicine with manipulation therapy on Korean Patients with Chronic Low Back Pain

Interventions

DRUGSogyeonghwalhyeol-tang granule

Sogyeonghwalhyeol-tang herbal extract granule

OTHERSogyeonghwalhyeol-tang granule with manipulation procedure

Sogyeonghwalhyeol-tang herbal extract granule with manipulation procedure

OTHERPlacebo with manipulation procedure

Placebo granule with manipulation procedure

Sponsors

Daejeon University
CollaboratorOTHER
Semyung University Korean Medicine Hospital in Chungju
CollaboratorUNKNOWN
Woosuk University Oriental Medical Center
CollaboratorUNKNOWN
Gachon University Gil Oriental Medical Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Inpatients with chief complaint of low back pain in oriental rehabilitation medical center * Age 19 - 65 * Patients who have 4 \ 7 cm of VAS pain score; * Ability to have normal communication * Ability to give informed consent

Exclusion criteria

* Patients with pain duration of 3 months or less * Patients with progressive neurologic deficit or severe neurologic symptoms by SLR test * Patients diagnosed with serious pathology(s) which may cause low back pain (e.g. spinal metastasis of tumor(s), acute fracture, etc) * Patients with spondylolisthesis or spondylolysis(diagnosed with grade II or higher level) * Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results * Patients with history of spinal surgery * Patients with more severe pain than pain caused by low back pain * Those who do not (cannot) abide by treatment and follow up due to the mental illness such as behavior disorder, depression, anxiety neurosis etc. * Patients with history of Medical Malpractice Case * Patients with treatment history of low back pain within 1 month either KM or WM * Patients participating in other clinical studies within 3 months * Pregnant patients or patients with plans of pregnancy or lactating patients * Patients disagree to sign the informed consent form * Patients deemed unsuitable for participating the trial by the researchers

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Numeric Rating Scale of PainScreening Visit, At baseline, week 2, 4, 6, 8A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) assesses the patients' current level of pain.

Secondary

MeasureTime frameDescription
Change from Baseline in 'Roland Morris Disability Questionnaire'Screening Visit, At baseline, week 2, 4, 6, 8This is a self-reported questionnaire consisting of 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, bending over, sitting, lying down, dressing, sleeping, self-care and daily activities.
Change from Baseline in European Quality of life 5 DimensionScreening Visit, At baseline, week 2, 4, 6, 8The EQ-5D is an international, standardized, generic instrument for describing and valuing health status. Participants were asked to indicate which of the following statements best describes their health state.

Other

MeasureTime frameDescription
Change from baseline in pelvic incidenceAt baseline, week 4, 8angle between the line perpendicular to the sacral plate and the line connecting the midpoint of the sacral plate to the bicoxofemoral axis.
Change from baseline in lumbar lordotic angleAt baseline, week 4, 8the angle between the top (superior surface) of the second lumbar vertebra and the bottom (inferior surface) of the fifth lumbar vertebra
Change from baseline in iliac crest heightAt baseline, week 4, 8A measure of the vertical distance from the top of the iliac crest to the floor while the subject stands.
Change from baseline in lumbar gravity lineAt baseline, week 4, 8created by first locating center of the L3 body & then droping a line downward from there, perpendicular to the bottom of the film.

Countries

South Korea

Contacts

Primary ContactYoume Ko, MA
iseeymk@gmail.com8229619278

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026